This New Article today from Investor Place says that SAVA is undervalued
$Cassava Sciences(SAVA.US$
This New Article today from Investor Place says that SAVA is undervalued and the potential of Simufilam after FDA approval. The price currently has been going down drastically to scare people to leave then regret later because no other drug has done this kind of improvement for Alzheimer’s. If you can stomach this and be patient, there’s great potential at end of this roller coaster. Knowing what you hold will have it’s day when everything clears up!!
This New Article today from Investor Place says that SAVA is undervalued and the potential of Simufilam after FDA approval. The price currently has been going down drastically to scare people to leave then regret later because no other drug has done this kind of improvement for Alzheimer’s. If you can stomach this and be patient, there’s great potential at end of this roller coaster. Knowing what you hold will have it’s day when everything clears up!!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
